Priovant Therapeutics, Inc.
Priovant Therapeutics, Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Brepocitinib in Adults With Cutaneous Sarcoidosis | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, immune system disorder, lymphatic system disorder, lymphoproliferative syndrome, sarcoidosis, skin sarcoidosis | Recruiting | Phase 2 / Phase 3 | 2026-08-27 | NCT06978725 | |
| A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris | Lichenoid Eruptions, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, lichen planopilaris, lichen planus, skin disorder | Recruiting | Phase 2 / Phase 3 | 2026-07-08 | NCT07532603 | |
| A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis | eye disorder, intermediate uveitis, panuveitis, posterior uveitis, uveal disorder, uveitis | Active, not recruiting | Phase 3 | 2026-01-12 | NCT06431373 |